Key result
Engineered yeast expressing guinea pig TASK-3 confirms antagonistic activity of PK-THPP, ZnCl2, and bupivacaine.
Why the study?
TASK potassium channel malfunctions are associated with diseases, making them popular drug targets, but identifying channel inhibitors can be time-consuming and expensive.
The BYT45 yeast system offers an inexpensive and accessible method for screening and characterizing TASK-3 potassium channel antagonists.
Offers inexpensive yeast-based TASK-3 screening; leaves clinical translation open pending mammalian validation.
Finding new potential antagonists of potassium channels is a continuing task. TASK potassium channels operate over a large physiological range of membrane voltages, why they are thought to contribute to the excitability and resting potential of mammalian membrane potentials. Additionally, they are regulated by extracellular stimuli like changes in pH and K+ concentrations. TASK malfunctions are associated with diseases, which makes them popular targets for the search of new antagonists. Identification of channel inhibitors can be a time-consuming and expensive project. Here, we present an easy-to-use and inexpensive yeast system for the expression of the two-pore domain K+ channel TASK-3, and for the characterization of TASK-3 antagonists. The Saccharomyces cerevisiae strain BYT45 was used to express guinea pig TASK-3. The system allowed the expression and characterization of TASK-3 at variable pH values and K+ concentrations. Three known TASK-3 antagonists have been tested in the BYT45 yeast system: PK-THPP, ZnCl2 and Bupivacaine. Their inhibitory effect on TASK-3 was tested in solid and liquid media assays, and half maximal inhibitory concentrations were estimated. Although the system is less sensitive than more refined systems, the antagonistic activity could be confirmed for all three inhibitors.
No takes yet. Share an insight, caveat, or question.
Riedelsberger et al. (2019) studied this question. PK-THPP, ZnCl2 and Bupivacaine was evaluated on Inhibitory effect on TASK-3. The Saccharomyces cerevisiae strain BYT45 successfully expressed guinea pig TASK-3 and confirmed the antagonistic activity of PK-THPP, ZnCl2, and Bupivacaine.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: